Net Change In Cash - VistaGen Therapeutics Inc (NASDAQ:VTGN) - Alpha Spread
V

VistaGen Therapeutics Inc
NASDAQ:VTGN

Watchlist Manager
VistaGen Therapeutics Inc
NASDAQ:VTGN
Watchlist
Price: 3 USD Market Closed
Market Cap: 81.2m USD
Have any thoughts about
VistaGen Therapeutics Inc?
Write Note

VistaGen Therapeutics Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

VistaGen Therapeutics Inc
Net Change in Cash Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
V
VistaGen Therapeutics Inc
NASDAQ:VTGN
Net Change in Cash
$93.3m
CAGR 3-Years
-1%
CAGR 5-Years
144%
CAGR 10-Years
77%
Abbvie Inc
NYSE:ABBV
Net Change in Cash
$4.4B
CAGR 3-Years
20%
CAGR 5-Years
22%
CAGR 10-Years
29%
Gilead Sciences Inc
NASDAQ:GILD
Net Change in Cash
-$2.9B
CAGR 3-Years
-17%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Change in Cash
-$24.9B
CAGR 3-Years
-115%
CAGR 5-Years
-40%
CAGR 10-Years
-33%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Change in Cash
-$5.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-48%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Change in Cash
-$21.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is VistaGen Therapeutics Inc's Net Change in Cash?
Net Change in Cash
93.3m USD

Based on the financial report for Jun 30, 2024, VistaGen Therapeutics Inc's Net Change in Cash amounts to 93.3m USD.

What is VistaGen Therapeutics Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
77%

The average annual Net Change in Cash growth rates for VistaGen Therapeutics Inc have been -1% over the past three years , 144% over the past five years , and 77% over the past ten years .

Back to Top